A pathology report is written to convey information concerning the pathologic ndings in a study. This type of report must be complete, accurate and communicate the relative importance of various ndings in a study. The overall quality of the report is determined by three Quality Indicators: thoroughness , accuracy, and consistency. Thoroughnes s is the identi cation of every lesion present in a particular organ or tissue, including spontaneous backgroun d lesions. Experienced pathologist s familiar with backgroun d lesions may disregard certain types of lesions or establish a threshold or a severity above which background lesions are diagnosed . Accuracy is the ability to make, and precisely communicate , correct diagnoses. Nomenclature of lesions is a matter of de nition and experienced pathologist s generally agree as to what terms are to be used. Consistency is the uniform use of a speci c term to record a de ned lesion and implies that the same diagnostic criteria are being followed for each type of diagnosis. The relative severity of nonneoplasti c lesions can be recorded either semiquantitatively or quantitatively. Semiquantitative analysis involves the application of de ned severity grades or ranges for speci c lesions. Quantitative analysis (counts and measurements) can be performed manually or electronically, utilizing image analysis and stereological techniques to provide numerical values. When both qualitative and quantitative parameters are applied in preparation of a pathology report, the recorded pathology ndings can be interpreted and put into perspective. The use of this approach assures a reader that the pathology report meets the highest standards.
INTRODUCTION
In toxicity and carcinogenicity studies, pathology reports are written in order to convey information concerning the pathologic ndings in a study. Such reports are read by pathologists and other scientists, and information from these reports is incorporated into documents that are subsequently submitted to regulatory agencies. Thus, these reports need to be complete, accurate, and convey the relative importance of the lesions identi ed in a study (1-3, 6, 17) . The identication of Quality Indicators of pathology reports not only assist in the production of quality reports but also serve as a guide for reviewers of these reports. These quality indicators can be divided into the two broad categories of recording observations and interpretation of those observations. Three primary quality indicators of recording observations in toxicologic pathology reports have been identi ed: thoroughness, accuracy, and consistency. The signi cance of nonneoplasti c lesions can be recorded either semiqualitatively by applying de ned severity grades or quantitatively by using image analysis and stereological techniques to provide numerical values for speci c lesions (9, 10, 13, 17) . Issues of "interpre-tation" fall into categories of identi cation of relationship to treatment, and explanation of importance and/or context. QUALITY INDICATORS OF RECORDING OBSERVATIONS "Thoroughness" can be de ned as the recording of all lesions, including the frequently observed, usually spontaneous incidental background lesions, present in a particular organ or tissue. An experienced pathologist is familiar with the background lesions typically seen in the particular animal species with which he or she is working. Thoroughness can be the key to identifying subtle changes that might be otherwise overlooked. The fact that treatment-related changes can be present in morphologically normal tissues is an important (but rarely discussed) concept in toxicologic pathology. This occurs because normal is actually an array of individual variations within an accepted reference range. For example, hepatocellular cytoplasmic vacuolization is a commonly observed nding in untreated control mice (4), and the appearance of this nding may vary substantially from animal to animal. However, if a pathologist elects to routinely ignore cytoplasmic vacuolization in both control and treated mice, a subtle treatment-related change in the comparative severity of vacuolization and potentially a correlation with hepatocellular metabolic injury is likely to be missed. Another essential aspect of thoroughness is that it may be dif cult to determine the degree of care put into the histopathologic 93 0192-6233/02$3.00 $0.00 evaluation of the study if it appears that all lesions have not been recorded. However, when all lesions are identi ed and graded, when necessary, there should be no questions relative to the thoroughness of tissue evaluation in a study. A lack of thoroughness also generates inaccurate statistical data for historical control databases; such databases can be invaluable aids in the interpretation of study ndings (8) .
Conversely, overly zealous lesion identi cation can result in an increase in the numbers and types of diagnoses recorded in studies. Therefore, to streamline the pathology reports, an experienced pathologist may make carefully considered, well-documented, predetermined decisions to exclude diagnosing certain types of ndings, that is, thyroid gland-ultimobranchial cysts, adrenal gland-accessory cortical nodules, and so forth.
The decision to discount speci c lesion types should not be confused with the concept of threshold, which is the conditional exclusion of ndings when they are below a certain level of severity (9) . In toxicologic pathology, some commonly used thresholds are understood rather than stated. For example, a diagnosis of in ammation is seldom based upon the observation of a few in ammatory cells. Less obvious types of thresholds may be set according to established criteria or they may be based on the personal experience of the study pathologist; in either case, these types of thresholds should be justi ed, consistently applied, and adequately de ned in the narrative portion of the pathology report. Unde ned thresholds can result in "diagnostic drift" and subtle changes in the incidence, severity, and distribution of a particular background lesion may not be detected (5) .
Many pathologists have the concern that their report will be reviewed by a nonpathologis t who will not understand the nuances of pathological interpretation and will identify various lesions as signi cant when they are of no biological signi cance. Although this is of concern, it should serve as a stimulus to the pathologist to put all of their ndings into clear perspective in their pathology reports.
"Accuracy" is the application of correct terminology when recording observed lesions (5, 7) . The evaluation of how accurate a pathologist was in applying terminology to a speci c lesion can be rather subjective in many cases because the assignment of speci c terminology may be a matter of professional opinion. One must remember, however, that lesion nomenclature is a matter of de nition and experienced pathologists generally agree as to what terms are to be used. A diagnosis is made by consecutively de ning the organ topography (eg, stomach, forestomach), site quali er when necessary (eg, epithelium), morphology (microscopic appearance or type of lesion) and severity grade when necessary (11, 12) . Although arguably less essential, it may be benecial in some instances to include a distribution quali er (eg, focal) and an indicator of chronicity (eg, acute). A pathologist must remember that his/her goal is not merely to render an accurate diagnosis but also to consolidate lesions having similar or identical locations and pathogenesis (eg, the individual components of "chronic progressive nephropathy") under a single term that adequately distinguishes a lesion for the purpose of evaluation and comparison. This can be a ne line, however, as the consolidation of too many lesions under a single term may obscure a treatment-related effect.
Consistency is the uniform use of a speci c term to record a de ned lesion. It implies that the same diagnostic criteria are being followed each time and that the nal diagnosis is achieved by consistently applied standards. Not surprisingly, unde ned or poorly de ned diagnostic criteria are dif cult to apply consistently and can be the cause of diagnostic drift (6) . Diagnostic drift occurs when diagnoses gradually and insidiously vary over time during the course of slide reading. A pathologist can minimize this problem by evaluating the tissues from animals in the various test groups in replicates of 5 to 10 animals instead of evaluating all the tissues from an entire group before subsequent groups. Additionally, a pathologist must always remember that with the exception of the severity grade, any difference in terminology, that is, topography, site, morphology, and/or distribution, de nes a separate and distinct diagnosis that therefore becomes a separate line entry in the summary tables.
Consistency is especially important (and challenging to maintain) in the determination of comparative lesion severity. In this area, consistency can usually be improved by the use of semiquantitative or quantitative observation recording.
As accuracy entails agreement among pathologists as to what terminology is to be used, efforts, such as those of the Society of Toxicologic Pathologists, to formulate standard terminology and criteria of diagnoses serve to increase the degree of accuracy and consistency within the profession (14) (15) (16) . Additionally, efforts to enhance the objectivity of observations should be encouraged. This includes processes that provide more de nitive measures of the nature of a particular lesion. For instance, the identi cation of activation or inactivation of particular genes may be important in determining the signi cance of a particular neoplastic process in the liver of a mouse. This type of information could supplement the morphologic characteristics to yield a more detailed de nition of the nature of the lesion. QUANTITATIVE RECORDING OF OBSERVATIONS Semiquantitative analysis of speci c nonneoplastic lesions in toxicologic pathology involves the application of severity grades. Severity grading is the application of de ned numerical (or numerically equivalent) severity scores of speci c lesions (5, 9, 10, 13, 18) . Severity grading is considered to be semiquantitative, because it most often relies on estimates of severity rather than actual measurements. For each disease process, severity grades are primarily determined by the extent or an estimate of the percent of tissue involvement as well as the magnitude of various components present.
Although severity grading is used in toxicologic studies, to date there are no standardized guidelines for grading nonneoplastic lesions. Most often, the severity of a change is an opinion rather than one that has been rigorously de ned. To maintain lesion consistency between studies, the severities of these lesions should be based on a consistent grading scheme with well-de ned criteria. The utilization of standardized guidelines for grading lesions can be useful in identifying subtle treatment-related effects that are not incidence based, as well as help maintain lesion consistency among different pathologists. Some factors that must be taken into consideration are: 1) the guidelines must be exible enough to accommodate different tissues and/or situations, 2) the grading ranges may be dif cult to estimate without morphometric measurements, Vol. 30, no 1, 2002
3) grades may not correlate well with the degree of physiologic alteration present within a particular tissue, and 4) the standardization of severity grade ranges may not take full advantage of the pathologist's training and experience. It is important to note that the severity grade scheme used, as well as the concept of thresholds, have a great bearing on the definition of the no observed effect level (NOEL), and therefore the conclusions derived from a study. Without a clear de nition of both the potential for erroneous conclusions increases.
The number of grading levels used by pathologists today vary greatly, with anywhere from 3 to 50 levels of effect being used to describe some lesions (10) . However, because there appears to be an inverse relationship between reproducibility and the number of grade levels, lower numbers of grade levels are considered better. In addition to the varying numbers of severity grade levels, the grading schemes vary from linear in fashion to disproportionately skewed (nonlinear), and they often lack de nition of the grade allocations. To ensure consistency between studies from the same facility or different facilities, all grading schemes should be allocated in an objective manner, whether linear or not. Unfortunately, it is not unusual to nd that lesions from subchronic studies are overgraded in comparison to chronic studies, because the grading criteria were applied differently. This can result in the erroneous appearance of some treatment-related effects becoming less severe with prolonged compound administration, when they actually may have worsened or even remained the same.
It should be relatively easy to allocate lesions into severity grades relative to the percentage of the tissue affected, that is, entire organ (liver), individual cell type (liver, hepatocytes), or region of an organ (liver periportal). As mentioned earlier, the number of categories or levels of severity used will affect the sensitivity, and reproducibility, of the exercise (too few grade levels results in a loss of sensitivity and too many severity grade levels and inconsistent categorization becomes dif cult for the pathologist to discern between grades). Although the nomenclature used for severity grading varies between laboratories, it appears that the most commonly used grading schemes include four or ve severity grades to which either descriptive terms (minimal, mild, moderate, etc) and/or numerical levels (grade 1, 2, 3, etc) are applied ( Table 1) . A more elaborate, detailed, description of an accepted severity grade scheme may also be of value ( Table 2) .
Failure of pathologists to ensure strict comparability of the results within or between studies, by not using de ned severity grading criteria, may render any statistical analysis of the pathology data useless.
Quantitative analysis involves the use of histological analytical methods that allocate numerical values to histologic ndings. Quantitative analytical methodologies such as automated or semi-automated image analysis and manual stereology provide prospective, planned, formal assessments of histologic samples. When these technologies are used, the collection and selection of samples is carefully and strictly controlled, in order to increase the consistency of the assessment and ultimately, to provide numerical values to ndings that are devoid of observer bias. Modern immunohistochemical methods for the demonstration of speci c cellular components may be extremely useful in the assessment of trophic, degenerative, proliferative, or reactive responses in tissues, and quanti cation of the reaction and of the reaction products can sometimes be achieved with a modest amount of effort using image-analysis. The methods for the conduct of quantitative evaluations commonly involve exhaustive histological sampling and preparation techniques. The use of modern computer-based, image-analysis still has limited usefulness in routine examinations, despite the potential for improved precision without signi cant human intervention. Manual methods for the quanti cation of lesions are inevitably time-consuming, tedious, and expensive although, in some instances, the time taken may be less than that required for the interactive use of image-analysis equipment. In laboratories that lack the resources for the acquisition of computer-based, imageanalysis equipment, manual methods may be the only means available. Comparisons of results from quantitative assessments, by manual methods and image-analysis, and careful semiquantitative evaluations often show no appreciable differences in the de nition of an effect of treatment, or a NOEL, and expensive quantitative procedures should be used judiciously. Whatever the methodology, most formal quantitative Grade 1 ( 1): Minimal. This corresponds to a histologic change that may be barely noticeable to changes considered so minor, small, or infrequent as to warrant no more than the least assignabl e grade (0-10%). For focal, multifocal or diffusely distributed lesions, this grade is used for processes where < 10% of the tissue is involved. For hyperplastic/hypoplastic/atrophic lesions, this grade is used when the affected structure or tissue has undergone < 10% increase or decrease in volume. Grade 2 ( 2): Mild. This corresponds to a histologic change that is a noticeable but not a prominent feature of the tissue. For focal, multifocal or diffusely distributed lesions, this grade is used for processes where between 11-20% of the tissue is involved. For hyperplastic/hypoplastic/atrophic lesions, this grade is used when the affected structure or tissue has undergon e between an 11% and 20% increase or decrease in volume. Grade 3 ( 3): Moderate. This corresponds to a histologic change that is a prominent feature of the tissue. For focal, multifocal or diffusely distributed lesions, this grade is used for processes where 21-40% of the tissue section is involved. For hyperplastic/hypoplastic/atrophic lesions, this grade is used when the affected structure or tissue has undergone between a 21% and 40% increase or decrease in volume. Grade 4 ( 4): Marked. This correspond s to a histologic change that is an overwhelming feature of the tissue. For focal, multifocal or diffusely distributed lesions, this grade is used for processes where 41-100% of the tissue section is involved. For hyperplastic/hypoplastic/atrophic lesions, this grade is used when the affected structure or tissue has undergone between a 41% and 100% increase or decrease in volume.
studies are expensive and time-consuming even though the results are more likely to be accepted as a representative, objective evaluation of a speci c change.
INTERPRETATION OF OBSERVATIONS All lesions that occur because of treatment, regardless of the severity of the lesions, should be identi ed and described in detail. Thoroughness, as discussed earlier, must be the basis for this interpretation, for only those lesions that are identi ed can be interpreted. The identi cation of a de nitive relationship to treatment can be made only after all observations are made, so as not to bias the observations. This would not be a problem with an indisputable lesion, such as moderate-to-marked hepatocellular necrosis but may present a problem with background lesions that may be increased or decreased in severity or incidence because of treatment. The adequate identi cation of treatment-related lesions also depends upon the proper handling of the controls. Controls cannot be used solely as reference standards for the concurrent study, as this necessitates that they be considered in a different context than the treated animals. Observations should be made relative to a reference standard other than the concurrent controls. This reference may be a collection of histologic preparations of tissues considered as "normal" for the species and strain being tested, a complete description of these tissues, or the memory of an experienced toxicologic pathologist. De ciencies in the latter include the dif culty in observing temporal "drift" in the severity or incidence of background lesions in a particular strain of animals and inconsistencies among individual pathologists thereby suggesting the need for a historical control database for nonneoplastic lesions (8) .
The majority of treatment-related lesions must not only be identi ed, but must be put into a context that a scientist not familiar with pathology can understand. The relative severity of the lesions and their importance to the test animals must be given. This involves drawing relationships between the morphologic lesions and parameters such as serum enzymes or organ weights. Often, it is desirable to hypothesize a plausible pathogenesis and possible reversibility or resolution of the lesions. This is often vital to give the reader of the report a basis for understanding the signi cance of the lesions. Hypothesis, however, should be clearly labeled such, to not mislead the reader regarding the factual nature of something that has not been tested.
Thoroughness in observation and identi cation or relationship to treatment will result in the identi cation of treatmentrelated lesions that are of little or no consequence to the animal (1). Because of relative dosages of the test article, differences in metabolism, or enzymatic functions of particular tissues, these lesions may be of no importance to humans. The pathologist has the responsibility to de ne these points and to put these lesions into proper context. Comments should be made when the pathologist feels that lesions might be statistically signi cant, or statistically signi cant but not biologically relevant. The credibility of the pathologist will be enhanced if the interpretation of the importance of the lesions is substantiated by factual information, such as differences in metabolic pathways, rather than by simple authoritarian statements.
CONCLUSIONS
Qualitative and quantitative factors of pathology reports are those factors that lead a reader of the report or a reviewer of the study to be assured that the study was conducted in a manner re ective of the highest standards of diligence and consistency. When these factors are applied in preparation of a pathology report, the recorded pathology ndings can be interpreted and put into perspective relative to treatment such that a knowledgeable scientist can understand the signi cance and relevance of the ndings.
